These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 2786062)

  • 1. Immunogenicity of Haemophilus influenzae type b polysaccharide-outer membrane protein conjugate vaccine in patients who acquired Haemophilus disease despite previous vaccination with type b polysaccharide vaccine.
    Granoff DM; Chacko A; Lottenbach KR; Sheetz KE
    J Pediatr; 1989 Jun; 114(6):925-33. PubMed ID: 2786062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoglobulin deficiency and idiotype expression in children developing Haemophilus influenzae type b disease after vaccination with conjugate vaccine. The Collaborative Study Group.
    Holmes SJ; Lucas AH; Osterholm MT; Froeschle JE; Granoff DM
    JAMA; 1991 Oct; 266(14):1960-5. PubMed ID: 1895474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunologic priming to capsular polysaccharide in infants immunized with Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine.
    Weinberg GA; Einhorn MS; Lenoir AA; Granoff PD; Granoff DM
    J Pediatr; 1987 Jul; 111(1):22-7. PubMed ID: 3110388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The biology of Haemophilus influenzae type b vaccination failure.
    Holmes SJ; Granoff DM
    J Infect Dis; 1992 Jun; 165 Suppl 1():S121-8. PubMed ID: 1588145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in the immunogenicity of three Haemophilus influenzae type b conjugate vaccines in infants.
    Granoff DM; Anderson EL; Osterholm MT; Holmes SJ; McHugh JE; Belshe RB; Medley F; Murphy TV
    J Pediatr; 1992 Aug; 121(2):187-94. PubMed ID: 1640282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity of Haemophilus b conjugate vaccine (meningococcal protein conjugate) in children with prior invasive Haemophilus influenzae type b disease.
    Walter EB; Moggio MV; Drucker RP; Wilfert CM
    Pediatr Infect Dis J; 1990 Sep; 9(9):632-5. PubMed ID: 2235187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and immunogenicity of haemophilus influenzae type B polysaccharide or conjugate vaccines in an elderly adult population.
    Lottenbach KR; Granoff DM; Barenkamp SJ; Powers DC; Kennedy D; Irby-Moore S; Homan SM; Mink CM
    J Am Geriatr Soc; 2004 Nov; 52(11):1883-7. PubMed ID: 15507066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro induction of IgG1 and IgG2 secretion by B cells of children who developed invasive haemophilus disease despite vaccination.
    Chacko A; Granoff DM
    Pediatr Res; 1991 Jul; 30(1):124-9. PubMed ID: 1891277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Avidity and bactericidal activity of antibody elicited by different Haemophilus influenzae type b conjugate vaccines. The Vaccine Study Group.
    Schlesinger Y; Granoff DM
    JAMA; 1992 Mar; 267(11):1489-94. PubMed ID: 1538539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haemophilus influenzae b polysaccharide revaccination: a continued role for the unconjugated vaccine.
    Pichichero ME; Bracikowski A; Sullivan R; Madore D; Anderson P
    Pediatr Infect Dis J; 1989 Jan; 8(1):20-3. PubMed ID: 2784202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity in infants of Haemophilus influenzae type B polysaccharide in a conjugate vaccine with Neisseria meningitidis outer-membrane protein.
    Einhorn MS; Weinberg GA; Anderson EL; Granoff PD; Granoff DM
    Lancet; 1986 Aug; 2(8502):299-302. PubMed ID: 2874327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response of 7- to 15-month-old infants to sequential immunization with Haemophilus influenzae type b-CRM197 conjugate and polysaccharide vaccines.
    Rothstein EP; Schiller RP; Girone JA; Hipp TJ; Souder RL; Bernstein HH; Madore DV; Johnson CL; Smith DH
    Am J Dis Child; 1991 Aug; 145(8):898-900. PubMed ID: 1858727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response to a Haemophilus influenzae type b diphtheria CRM197 conjugate vaccine in children with a defect of antibody production to Haemophilus influenzae type b polysaccharide.
    Schneider LC; Insel RA; Howie G; Madore DV; Geha RS
    J Allergy Clin Immunol; 1990 May; 85(5):948-53. PubMed ID: 2332568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and immunogenicity of a Haemophilus influenzae type b conjugate vaccine in a high risk American Indian population.
    Santosham M; Hill J; Wolff M; Reid R; Lukacs L; Ahonkhai V
    Pediatr Infect Dis J; 1991 Feb; 10(2):113-7. PubMed ID: 2062601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IgG subclass response to immunization with Haemophilus influenzae type b polysaccharide-outer membrane protein conjugate vaccine.
    Granoff DM; Weinberg GA; Shackelford PG
    Pediatr Res; 1988 Aug; 24(2):180-5. PubMed ID: 3263612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemophilus influenzae type B disease in children vaccinated with type B polysaccharide vaccine.
    Granoff DM; Shackelford PG; Suarez BK; Nahm MH; Cates KL; Murphy TV; Karasic R; Osterholm MT; Pandey JP; Daum RS
    N Engl J Med; 1986 Dec; 315(25):1584-90. PubMed ID: 3491315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The immunogenicity of three Haemophilus influenzae type B conjugate vaccines after a primary vaccination series in Philippine infants.
    Capeding MR; Nohynek H; Pascual LG; Kayhty H; Sombrero LT; Eskola J; Ruutu P
    Am J Trop Med Hyg; 1996 Nov; 55(5):516-20. PubMed ID: 8940983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective immunogenicity of Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine in children who failed to respond to prior invasive H. influenzae type b disease.
    Berthet F; Prehn A; Suter R; Ethevenaux C; Seger RA
    Pediatr Allergy Immunol; 1998 Aug; 9(3):156-60. PubMed ID: 9814731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity of Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine in 2- to 6-month-old infants.
    Lenoir AA; Granoff PD; Granoff DM
    Pediatrics; 1987 Aug; 80(2):283-7. PubMed ID: 3112729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistence of antibody responses to Haemophilus influenzae type b polysaccharide conjugate vaccine in children with vertically acquired human immunodeficiency virus infection.
    Gibb D; Giacomelli A; Masters J; Spoulou V; Ruga E; Griffiths H; Kroll S; Giaquinto C; Goldblatt D
    Pediatr Infect Dis J; 1996 Dec; 15(12):1097-101. PubMed ID: 8970219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.